Last reviewed · How we verify
Topical antihistamine and vasoconstrictor
Topical antihistamines and vasoconstrictors work by reducing itching and swelling caused by allergic reactions, and constricting blood vessels to reduce redness and inflammation.
Topical antihistamines and vasoconstrictors work by reducing itching and swelling caused by allergic reactions, and constricting blood vessels to reduce redness and inflammation. Used for Relief of itching and inflammation associated with allergic reactions such as hives and insect bites.
At a glance
| Generic name | Topical antihistamine and vasoconstrictor |
|---|---|
| Also known as | Hista-oph |
| Sponsor | Khon Kaen University |
| Drug class | Topical antihistamine and vasoconstrictor |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
They do this by blocking histamine receptors, which are involved in allergic reactions, and causing blood vessels to constrict, which reduces blood flow to the affected area. This combination of actions helps to relieve symptoms such as itching, redness, and swelling.
Approved indications
- Relief of itching and inflammation associated with allergic reactions such as hives and insect bites
Common side effects
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: